Molecular Pathogens 2024, Vol.15, No.2, 61-71 http://microbescipublisher.com/index.php/mp 71 Tse L., Meganck R., Graham R., and Baric R., 2020, The current and future state of vaccines, antivirals and gene therapies against emerging coronaviruses, Frontiers in Microbiology, 11: 658. https://doi.org/10.3389/fmicb.2020.00658 Vrba S., Kirk N., Brisse M., Liang Y., and Ly H., 2020, Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats, Vaccines, 8(4): 680. https://doi.org/10.3390/vaccines8040680 Warimwe G., Francis M., Bowden T., Thumbi S., and Charleston B., 2021, Using cross-species vaccination approaches to counter emerging infectious diseases, Nature Reviews Immunology, 21: 815-822. https://doi.org/10.1038/s41577-021-00567-2
RkJQdWJsaXNoZXIy MjQ4ODYzNA==